Post G8 Briefing: Future Financing to Address the Global HIV/AIDS Epidemic
The Kaiser Family Foundation has issued a report that provides a detailed look at funding for the global HIV/AIDS epidemic by major donors.
The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
The Kaiser Family Foundation has issued a report that provides a detailed look at funding for the global HIV/AIDS epidemic by major donors.
This report from the The Center for Strategic and International Studies (CSIS) Task Force on HIV/AIDS Working Committee on Prevention, in collaboration with the Kaiser Family Foundation, provides an overview of the HIV prevention indicators used by the
The Center for Strategic and International Studies (CSIS) Task Force on HIV/AIDS, co-chaired by Senators Bill Frist (R-TN) and Russell Feingold (D-WI), outlines strategic choices that the United States faces in fighting the global HIV/AIDS pandemic.
The National ADAP Monitoring Report, 2005 provides the latest data on state AIDS Drug Assistance Programs (ADAPs). ADAPs, authorized under Title II of the Ryan White Comprehensive AIDS Resources Emergency (CARE) Act, provide HIV/AIDS-related prescription drugs to uninsured and underinsured individuals living with HIV/AIDS. ADAPs operate in 57 U.S. states, territories, and associated jurisdictions.
The National ADAP Monitoring Report, 2005 provides the latest data on state AIDS Drug Assistance Programs (ADAPs). ADAPs, authorized under Title II of the Ryan White Comprehensive AIDS Resources Emergency (CARE) Act, provide HIV/AIDS-related prescription drugs to uninsured and underinsured individuals living with HIV/AIDS. ADAPs operate in 57 U.S. states, territories, and associated jurisdictions.
Overview and Briefing Charts This chartpack reviews the President’s FY 2006 budget request to Congress and highlights overall budget assumptions and funding for major health programs. It begins with a description of the federal budget process, followed by an overview of federal surplus/deficit spending patterns dating back to 1969.
This policy brief, prepared by the Kaiser Family Foundation and the George Washington University Center for Health Services Research and Policy, examines the opportunities and challenges associated with the delivery of HIV prevention services in, or closely linked to, the clinical care setting.
Waiting lists are a reality of state AIDS Drug Assistance Programs (ADAPs), which rely on specific federal appropriations, or capped funding, each year. Capped funding determines ADAP’s income eligibility criteria, the number of drugs in the formulary, and the number of people who can be served.
AIDS Drug Assistance Program (ADAP) waiting lists have been an ongoing challenge for people with HIV/AIDS in many states. On June 23, 2004 President Bush announced the availability of an additional $20 million for HIV medications for the 10 states that had ADAP waiting lists at that time.
World AIDS Day began in 1988 to focus global attention on the HIV/AIDS epidemic across countries, organizations and governments. The theme of focuses on women, girls, and HIV and AIDS and seeks to explore how gender inequality fuels the AIDS epidemic.
© 2025 KFF